The Immune System – Webinars and Online Events

In this webinar, Dr. Theo Roth will discuss how CRISPR-All can be used to push human genetics beyond their evolved functionality, enabling researchers to engineer synthetic cell states with therapeutic potential.

Learn how to choose non-human primate and murine models that boost translational relevance in in vivo pharmacology, focusing on antibody–drug conjugates, T-cell engagers, and Fc-engineered antibodies.

This session will delve into the latest strategies and technologies that maximize transfection efficiency, cell proliferation and cytotoxic activity against cancer cells.

This webinar will highlight how the evaluation of IS formation at the single-cell level can support the discovery of new immunotherapies.

This event will feature discussions on novel immune checkpoint inhibitors, personalized cancer vaccines and CAR T-Cell therapies. We will also address the challenges of translating basic research into clinical practice and future directions.

Join this engaging webinar series exploring the critical connections between cellular metabolism and advancements in cancer research.

Dr. Finlay discusses how cellular metabolism affects NK cell responses to tumors and viral infections, highlighting how metabolic engineering can improve NK cell function in challenging microenvironments.

Dr. Jessica E. Thaxton discusses how metabolic stress in tumors affects immune cells, focusing on modulating T cells for lipid use and the role of Acetyl-CoA Carboxylase in limiting anti-tumor immunity.

Nutrient access and metabolism regulate lymphocyte function, crucial in demanding environments like tumors. Dr. Delgoffe explores T cell metabolic defects in solid tumors and unveils strategies to modulate these pathways, enhancing immune responses t

Immune cell activation, differentiation and function are metabolically demanding processes, and it has now become clear that nutrient access and metabolism play a major role in regulating lymphocyte fate and function. These axes of regulation are crucially important in shaping the immune system when it is activating in metabolically demanding environments, such as tumor tissue. Indeed, the immune response to cancer is characterized by several metabolic defects. In this webinar, Dr. Delgoffe will discuss some of these metabolic insufficiencies within the T cell compartment of solid tumors and reveal novel insights into how these metabolic nodes may be modulated to improve the immune response to cancer.